Barth syndrome

Barth syndrome (BTHS), also known as 3-methylglutaconic aciduria type II, is an extremely rare X-linked multisystem disorder that is usually diagnosed in infancy.

Barth syndrome has an estimated prevalence of 1 in 300,000-400,000 live births.

It is characterized by:

Barth syndrome is caused by a mutated tafazzin (TAZ) gene (chromosome Xq28) which encodes an acyltransferase responsible for remodeling of cardiolipin in mitochondrial membranes, especially affecting cardiac myocytes, neutrophils and skeletal muscles. The inheritance pattern is X-linked recessive type 6.

Echocardiography may reveal left ventricular dilatation, hypertrophy of left ventricle and endocardial fibroelastosis. Cardiomyopathy can develop in utero 6.

It was first described by P G Barth et al. 2-4  in the year 1983.

Share article

Article information

rID: 15721
Section: Syndromes
Synonyms or Alternate Spellings:
  • Barth syndrome (BTHS)
  • Barth's syndrome
  • X-linked cardioskeletal myopathy
  • 3-methylglutaconic acid-uria type II
  • Endocardial fibroelastosis type 2
  • Cardioskeletal Myopathy, Barth Type
  • Cardioskeletal Myopathy With Neutropenia and Abnormal Mitochondria
  • X-Linked Cardioskeletal Myopathy and Neutropenia

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.